Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT04397458
Other study ID # HSC-MS-20-0124
Secondary ID
Status Withdrawn
Phase Phase 4
First received
Last updated
Start date January 1, 2022
Est. completion date June 30, 2022

Study information

Verified date November 2023
Source The University of Texas Health Science Center, Houston
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess whether quadratus lumborum (QL) block performed 1 day after cesarean delivery will provide supplemental post-cesarean analgesia and reduce opioid requirements.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date June 30, 2022
Est. primary completion date June 30, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - elective or non-elective cesarean delivery on prior day - pain scores >5/10 Exclusion Criteria: - BMI >40 - obstructive sleep apnea - drug abuse - chronic pain - chronic opioid use - abdominal surgeries other than cesarean delivery - contraindications to neuraxial or regional anesthesia - received general anesthesia or did not receive neuraxial morphine for cesarean delivery

Study Design


Intervention

Drug:
Saline
0.9% saline on each side
Bupivacaine
0.25% bupivacaine (50mg) on each side
Dexamethasone
3mg preservative-free dexamethasone on each side

Locations

Country Name City State
United States The University of Texas Health Science Center at Houston Houston Texas

Sponsors (1)

Lead Sponsor Collaborator
The University of Texas Health Science Center, Houston

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Total opioid consumption 48 hours after intervention
Secondary Amount of opioids used at the time of intervention (one day following cesarean delivery)
Secondary Amount of opioids used 6 hours after intervention
Secondary Amount of opioids used 12 hours after intervention
Secondary Amount of opioids used 24 hours after intervention
Secondary Amount of opioids used 48 hours after intervention
Secondary Time from quadratus lumborum block until first opioid request from time of intervention until time of first opioid request (up to 48 hours)
Secondary Pain as measured by an 11-point verbal pain score (at rest) The 11-point verbal pain score ranges from 0-10, with a higher number indicating worse pain. at the time of intervention (one day following cesarean delivery)
Secondary Pain as measured by an 11-point verbal pain score (with movement) The 11-point verbal pain score ranges from 0-10, with a higher number indicating worse pain. at the time of intervention (one day following cesarean delivery)
Secondary Pain as measured by an 11-point verbal pain score (at rest) The 11-point verbal pain score ranges from 0-10, with a higher number indicating worse pain. 6 hours after intervention
Secondary Pain as measured by an 11-point verbal pain score (with movement) The 11-point verbal pain score ranges from 0-10, with a higher number indicating worse pain. 6 hours after intervention
Secondary Pain as measured by an 11-point verbal pain score (at rest) The 11-point verbal pain score ranges from 0-10, with a higher number indicating worse pain. 12 hours after intervention
Secondary Pain as measured by an 11-point verbal pain score (with movement) The 11-point verbal pain score ranges from 0-10, with a higher number indicating worse pain. 12 hours after intervention
Secondary Pain as measured by an 11-point verbal pain score (at rest) The 11-point verbal pain score ranges from 0-10, with a higher number indicating worse pain. 24 hours after intervention
Secondary Pain as measured by an 11-point verbal pain score (with movement) The 11-point verbal pain score ranges from 0-10, with a higher number indicating worse pain. 24 hours after intervention
Secondary Pain as measured by an 11-point verbal pain score (at rest) The 11-point verbal pain score ranges from 0-10, with a higher number indicating worse pain. 48 hours after intervention
Secondary Pain as measured by an 11-point verbal pain score (with movement) The 11-point verbal pain score ranges from 0-10, with a higher number indicating worse pain. 48 hours after intervention
Secondary Nausea as measured by a 3-point scale This is measured categorically as none, mild, or moderate-severe. at the time of intervention (one day following cesarean delivery)
Secondary Nausea as measured by a 3-point scale This is measured categorically as none, mild, or moderate-severe. 6 hours after intervention
Secondary Nausea as measured by a 3-point scale This is measured categorically as none, mild, or moderate-severe. 12 hours after intervention
Secondary Nausea, pruritus and sedation as measured by a 3-point scale This is measured categorically as none, mild, or moderate-severe. 24 hours after intervention
Secondary Nausea as measured by a 3-point scale This is measured categorically as none, mild, or moderate-severe. 48 hours after intervention
Secondary Pruritus as measured by a 3-point scale This is measured categorically as none, mild, or moderate-severe. at the time of intervention (one day following cesarean delivery)
Secondary Pruritus as measured by a 3-point scale This is measured categorically as none, mild, or moderate-severe. 6 hours after intervention
Secondary Pruritus as measured by a 3-point scale This is measured categorically as none, mild, or moderate-severe. 12 hours after intervention
Secondary Pruritus as measured by a 3-point scale This is measured categorically as none, mild, or moderate-severe. 24 hours after intervention
Secondary Pruritus as measured by a 3-point scale This is measured categorically as none, mild, or moderate-severe. 48 hours after intervention
Secondary Sedation as measured by a 3-point scale This is measured categorically as none, mild, or moderate-severe. at the time of intervention (one day following cesarean delivery)
Secondary Sedation as measured by a 3-point scale This is measured categorically as none, mild, or moderate-severe. 6 hours after intervention
Secondary Sedation as measured by a 3-point scale This is measured categorically as none, mild, or moderate-severe. 12 hours after intervention
Secondary Sedation as measured by a 3-point scale This is measured categorically as none, mild, or moderate-severe. 24 hours after intervention
Secondary Sedation as measured by a 3-point scale This is measured categorically as none, mild, or moderate-severe. 48 hours after intervention
Secondary Patient satisfaction as measured by the 5-point Likert scale The 5-point scale ranges from extremely satisfied to not satisfied. 48 hours after intervention
See also
  Status Clinical Trial Phase
Completed NCT03380533 - Buprenorphine Transdermal Patches in Arthroscopic Rotator Cuff Repair Phase 2/Phase 3
Completed NCT05004519 - Benefits of Opioid Free Anesthesia on Morphine Consumption in Gastric Bypass N/A
Not yet recruiting NCT04836169 - Phase 1: Randomized Evaluation of a System to Deliver Mobile Cognitive Behavioral Therapy N/A
Completed NCT02987985 - Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy Phase 3
Active, not recruiting NCT03366805 - A Patient Education Video Program for Post-Operative Recovery After Upper Extremity Surgery N/A
Completed NCT04818086 - Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder Phase 1/Phase 2
Recruiting NCT04144933 - Effect of Multimodal Opioid-free Anesthesia on Return of Bowel Function in Laparoscopic Colorectal Surgery Phase 3
Completed NCT04369950 - Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine Phase 4
Recruiting NCT05842928 - Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polypharmacy N/A
Recruiting NCT03485430 - Tapering From Long-term Opioid Therapy in Chronic Pain Population. Randomized Controlled Trial With 12 Months Follow up N/A
Completed NCT05099055 - Dexmedetomine as Adjuvant for Spinal Anesthesia in Elective Cesarian Sections : a Pilot Study Phase 3
Completed NCT03858621 - Comparison of Postoperative Nociception Between NOL-guided and Standard Intraoperative Analgesia Based on Fentanyl N/A
Recruiting NCT06390046 - Opioid-free Anesthesia, Optimization of Anesthesia After Bariatric Surgery N/A
Recruiting NCT06380244 - Opioid-free Anesthesia as an Alternative to General Anesthesia in Abdominal Surgery N/A
Completed NCT03991546 - Pain and Narcotic Usage After Orthopaedic Surgery N/A
Withdrawn NCT02985177 - A RCT of a Combination of Analgesics for Pain Management in Children With a Suspected Fracture Phase 4
Completed NCT05581901 - Perioperative Methadone in Hip Fracture Patients Phase 4
Completed NCT03294109 - Evaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectomy Phase 4
Completed NCT04204967 - Totally Transdermal Sedation in the Weaning From Remifentanil Infusion Phase 2
Completed NCT02665429 - A Quality Improvement Project to Investigate Individual Provider Variation in Opioid Prescribing From the Emergency Department N/A